You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic colorectal cancer (mCRC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Oct 13, 2023

Colorectal Cancer Trial (Regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 17, 2023

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Overall Survival in Metastatic Colorectal Cancer (mCRC)

Completed
  • Metastatic Colorectal Cancer (mCRC)
    • Princeton, New Jersey
      Local Institution
    Jun 13, 2022

    Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • +2 more
    • Eye90 Microspheres
    • Grafton, New Zealand
      Auckland District Health Board
    Jan 30, 2023

    Metastatic Colorectal Cancer Trial in China (HLX10/Placebo, HLX04/Avastin)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Guangzhou, Guangdong, China
    • +3 more
    Dec 19, 2022

    Metastatic Colorectal Cancer, mCRC Trial in Shenyang (HLX208)

    Recruiting
    • Metastatic Colorectal Cancer
    • mCRC
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital
    May 1, 2022

    Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Sep 8, 2023

    CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

    Withdrawn
    • CCR5
    • +3 more
    • 700mg leronlimab weekly dose
    • +3 more
    • (no location specified)
    Feb 15, 2023

    Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Regorafenib (Stivarga, BAY73-4506)
    • Hyderabad, Andhra Pradesh, India
    • +12 more
    Jan 13, 2023

    Called STAR-T to Learn More About Sequential Treatment With

    Not yet recruiting
    • Metastatic Colorectal Cancer (mCRC)
    • Regorafenib (BAY73-4506, Stivarga®)
    • +2 more
    • Whippany, New Jersey
      Many locations
    Apr 21, 2023

    Colon Cancer Liver Metastasis Trial in United States (Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution,

    Terminated
    Has Results
    • Colon Cancer Liver Metastasis
    • Lyso-Thermosensitive Liposomal Doxorubicin
    • +2 more
    • Los Angeles, California
    • +3 more
    Sep 15, 2022

    Metastatic Colorectal Cancer, No Evidence of Disease Status, ctDNA Monitoring Trial in Shanghai (ctDNA and adjuvant therapy,

    Recruiting
    • Metastatic Colorectal Cancer
    • +2 more
    • ctDNA and adjuvant therapy
    • ctDNA
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 22, 2022

    New Patient Stratification Tools in MSS RAS mt mCRC

    Completed
    • Advanced Colorectal Cancer
      • Heidelberg, Germany
      • +9 more
      Nov 25, 2022

      CRC Trial in Beijing (HL-085, Vemurafenib)

      Not yet recruiting
      • CRC
      • Beijing, Beijing, China
        Beijing Oncology Hospital
      Feb 6, 2022

      Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

      Completed
      Has Results
      • Metastatic Colorectal Cancer
      • MSS
      • Heidelberg, Germany
        National Center for Tumor Diseases, University Hospital Heidelbe
      May 17, 2022

      Metastatic Colorectal Cancer Trial in Providence (Dose level 1 ONC201 625mg, Dose level 2 ONC201 500mg, Dose level 3 ONC201

      Terminated
      Has Results
      • Metastatic Colorectal Cancer
      • Dose level 1 ONC201 625mg
      • +2 more
      • Providence, Rhode Island
        Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
      May 25, 2022

      Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

      Recruiting
      • Metastatic Colorectal Cancer (Mcrc)
      • +7 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Madrid, Spain
        Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
      Oct 10, 2022

      Metastatic Colorectal Cancer (mCRC) Trial in Nanjing (HLX04 100 mg in 4 ml Injection, Avastin 100 mg in 4 ml Injection)

      Active, not recruiting
      • Metastatic Colorectal Cancer (mCRC)
      • HLX04 100 mg in 4 ml Injection
      • Avastin 100 mg in 4 ml Injection
      • Nanjing, Jiangsu, China
        Nanjing Bayi Hospital Ethics Committee
      May 6, 2022

      CRC Trial in Shanghai (HLX208, Cetuximab Injection [Erbitux])

      Recruiting
      • CRC
      • HLX208
      • Cetuximab Injection [Erbitux]
      • Shanghai, China
        Fudan University Affiliated Oncology Hospital
      Dec 30, 2021

      Metastatic Colorectal Cancer Trial in Duarte, St Leonards (Magrolimab, Bevacizumab, Irinotecan)

      Recruiting
      • Metastatic Colorectal Cancer
      • Magrolimab
      • +4 more
      • Duarte, California
      • +19 more
      Jan 27, 2023

      Metastatic Colorectal Cancer (mCRC) Trial in France (Regorafenib, Irinotecan)

      Recruiting
      • Metastatic Colorectal Cancer (mCRC)
      • Nice, Alpes-Maritimes, France
      • +10 more
      Jan 16, 2023

      Metastatic Colorectal Cancer Trial in United States (Rivoceranib, Trifluridine/Tipiracil)

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Sarasota, Florida
      • +3 more
      May 18, 2022